基本信息
浏览量:7
职业迁徙
个人简介
Description of Research Expertise
Hereditary Breast Cancer
The research in the Nathanson Group in hereditary breast and ovarian cancer started when I was post-doctoral fellow, training under Dr. Barbara Weber. Most recently, we have published studies demonstrating variable risks of breast and ovarian cancers with differing mutation types and locations with BRCA1 and BRCA2 (JAMA, 2015), and described the world-wide distribution of mutations (Hum Mutat, 2018). My group has evaluated the rate of moderate risk gene mutations in early onset breast cancer (Genet Med, 2015; NPJ Breast Cancer ,2017), contributed to consensus statements on the risk of these mutations (NEJM, 2015; Nat Rev Clinic Oncol, 2016), and evaluated the use of the ACMG guidelines for variant annotation of these genes (Am J Hum Genet, 2016). We published a somatic characterization of tumors associated with BRCA1/2 germline mutations and demonstrated that a significant proportion do not have allele-specific loss of heterozygosity, associated with differential genetic/genomic characteristics and survival after treatment (Nat Comm, 2017). We have preliminary data following up.
Example Projects:
1) Identification of novel breast cancer susceptibility genes using large scale sequencing in high risk and case-control cohort studies
2) Characterization of moderate penetrance breast cancer susceptibility genes in large cohorts
3) Characterization of immunogenicity in BRCA1/2 mutation associated cancers, understanding the associated molecular features and role of aneuploidy (working with cancer immunologists at Penn Medicine)
4) Understanding tumor heterogeneity in BRCA1/2 mutation associated cancers, by using single cell sequencing, high-depth targeted sequencing and large scale
5) Working with Dr. E. John Wherry’s group to elucidate immune function in healthy BRCA1/2 mutation carriers
Hereditary Breast Cancer
The research in the Nathanson Group in hereditary breast and ovarian cancer started when I was post-doctoral fellow, training under Dr. Barbara Weber. Most recently, we have published studies demonstrating variable risks of breast and ovarian cancers with differing mutation types and locations with BRCA1 and BRCA2 (JAMA, 2015), and described the world-wide distribution of mutations (Hum Mutat, 2018). My group has evaluated the rate of moderate risk gene mutations in early onset breast cancer (Genet Med, 2015; NPJ Breast Cancer ,2017), contributed to consensus statements on the risk of these mutations (NEJM, 2015; Nat Rev Clinic Oncol, 2016), and evaluated the use of the ACMG guidelines for variant annotation of these genes (Am J Hum Genet, 2016). We published a somatic characterization of tumors associated with BRCA1/2 germline mutations and demonstrated that a significant proportion do not have allele-specific loss of heterozygosity, associated with differential genetic/genomic characteristics and survival after treatment (Nat Comm, 2017). We have preliminary data following up.
Example Projects:
1) Identification of novel breast cancer susceptibility genes using large scale sequencing in high risk and case-control cohort studies
2) Characterization of moderate penetrance breast cancer susceptibility genes in large cohorts
3) Characterization of immunogenicity in BRCA1/2 mutation associated cancers, understanding the associated molecular features and role of aneuploidy (working with cancer immunologists at Penn Medicine)
4) Understanding tumor heterogeneity in BRCA1/2 mutation associated cancers, by using single cell sequencing, high-depth targeted sequencing and large scale
5) Working with Dr. E. John Wherry’s group to elucidate immune function in healthy BRCA1/2 mutation carriers
研究兴趣
论文共 700 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Human molecular genetics (2024)
Anton Safonov,Antonio Marra,Chaitanya Bandlamudi, Ben O'Leary,Bradley Wubbenhorst, Enrico Moiso,Minna Lee,Mark Donoghue, Julia Ah-Reum An,Marie Will, Fresia Pareka,Mehnaj Ahmed,
biorxiv(2024)
Mwangala P. Akamandisa,Bradley Wubbenhorst, Kurt D'Andrea,Heather Symecko, Rhonda Gillette,Payal D. Shah,Angela R. Bradbury,Kara N. Maxwell,Susan M. Domchek,Katherine L. Nathanson
CANCER RESEARCHno. 3 (2024)
Khalid Y. Alkhatib, Ian Mitchell Harmatz,John Pluta, Morgan Leff,Brian D. Cortese, Nathaniel McLaughlan,Thomas Guzzo,Katherine L. Nathanson,David J. Vaughn,Phillip M. Pierorazio,Daniel J. Lee
medRxiv : the preprint server for health sciences (2024)
Kasturee Jagirdar,Marie E. Portuallo,Meihan Wei, Matthew Wilhide, Jeremy A. Bravo Narula, Bailey M. Robertson,Gretchen M. Alicea,Crystal Aguh, Min Xiao,Tetiana Godok,Dylan Fingerman,Gregory Schuyler Brown,
ONCOGENEno. 6 (2024): 395-405
Angela Bradbury,Elisabeth Wood, Lillian Phung,Brian Egleston, Demetrios Ofidis, Rajia Mim, Sarah Howe,Lily Hoffman-Andrews,Anjali Owens,Susan Domchek,Reed Pyeritz,Bryson Katona,
Genetics in Medicine Open (2024): 101794
Cancer Genetics (2024)
Kasturee Jagirdar,Marie E. Portuallo,Meihan Wei, Matthew Wilhide,Jeremy A. Bravo Narula, Bailey M. Robertson,Gretchen M. Alicea, Crystal Aguh,Min Xiao,Tetiana Godok,Dylan Fingerman,Gregory Schuyler Brown,
Research squareno. 6 (2024): 395-405
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn